These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28712356)

  • 21. Gaining Autonomy & [corrected] Medication Management (GAM): new perspectives on well-being, quality of life and psychiatric medication.
    del Barrio LR; Cyr C; Benisty L; Richard P
    Cien Saude Colet; 2013 Oct; 18(10):2879-87. PubMed ID: 24061014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Narratives of users of mental health services in an experiment with autonomous management of medication].
    Gonçalves LLM; Campos RTO
    Cad Saude Publica; 2017 Nov; 33(11):e00166216. PubMed ID: 29166486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication compliance behavior in psychiatric out-patients with psychoactive substance use comorbidity in a Nigerian tertiary hospital.
    Okpataku CI; Kwanashie HO; Ejiofor JI; Olisah VO
    Niger J Clin Pract; 2015; 18(3):371-6. PubMed ID: 25772921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subjectivity and autonomy: meanings and narratives with respect to discontinuing psychiatric drugs].
    Parada TC
    Salud Colect; 2018; 14(3):513-529. PubMed ID: 30517560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Accounts of the Process of Using and Discontinuing Psychiatric Medication.
    Katz S; Goldblatt H; Hasson-Ohayon I; Roe D
    Qual Health Res; 2019 Jan; 29(2):198-210. PubMed ID: 30132725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescent experience of psychotropic treatment.
    Floersch J; Townsend L; Longhofer J; Munson M; Winbush V; Kranke D; Faber R; Thomas J; Jenkins JH; Findling RL
    Transcult Psychiatry; 2009 Mar; 46(1):157-79. PubMed ID: 19293284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The psychoactive effects of psychiatric medication: the elephant in the room.
    Moncrieff J; Cohen D; Porter S
    J Psychoactive Drugs; 2013; 45(5):409-15. PubMed ID: 24592667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autonomous Medication Management: an analytical intervention in mental health care services].
    Onocko-Campos RT; Passos E; Palombini Ade L; dos Santos DV; Stefanello S; Lamas LG; de Andrade PM; Borges LR
    Cien Saude Colet; 2013 Oct; 18(10):2889-98. PubMed ID: 24061015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing.
    Linsky A; Meterko M; Stolzmann K; Simon SR
    BMC Health Serv Res; 2017 Jun; 17(1):447. PubMed ID: 28659157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence.
    Stein BD; Kogan JN; Mihalyo MJ; Schuster J; Deegan PE; Sorbero MJ; Drake RE
    Community Ment Health J; 2013 Apr; 49(2):185-92. PubMed ID: 22837104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceived effectiveness of medications among mental health service users with and without alcohol dependence.
    Edlund MJ; Harris KM
    Psychiatr Serv; 2006 May; 57(5):692-9. PubMed ID: 16675765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Sep; 16(5):306-24. PubMed ID: 20859108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice.
    Einarson A
    J Obstet Gynaecol Can; 2005 Nov; 27(11):1019-22. PubMed ID: 16529668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure.
    de Kuijper GM; Hoekstra PJ
    J Clin Pharmacol; 2018 Nov; 58(11):1418-1426. PubMed ID: 29920689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short- and long-term results of a systematic benzodiazepine discontinuation programme for psychiatric patients].
    Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):683-93. PubMed ID: 17007474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal.
    Liebrenz M; Gehring MT; Buadze A; Caflisch C
    BMC Psychiatry; 2015 May; 15():116. PubMed ID: 25968120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic Polypharmacy and Antipsychotics in Children: A Survey of Caregiver's Perspectives.
    McLaren JL; Barnett ER; Acquilano SC; Concepcion Zayas MT; Drake RE; Leyenaar JK
    Community Ment Health J; 2022 Apr; 58(3):512-516. PubMed ID: 34057662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital.
    Abdullah-Koolmees H; Gardarsdottir H; Yazir D; Stoker LJ; Vuyk J; Egberts TC; Heerdink ER
    Ann Pharmacother; 2015 Oct; 49(10):1085-95. PubMed ID: 26160969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.